
SFARI is pleased to announce that it has awarded four grants in response to the Novel Outcome Measures for ASD Clinical Trials request for applications. These grants will support research that aims to develop and validate objective measures for use in clinical trials targeting core symptoms of ASD and disruptive behavioral symptoms commonly reported in individuals with ASD.








